Total Pageviews

Monday, July 22, 2013

A greedy man in a hungry world

“A greedy man in a hungry world” is the title of a new book by Jay Rayner, an award winning author, journalist and most notably, restaurant critic. Anybody seriously interested in the food chain should read this book. It is highly informative, funny and embraces a fair degree of autobiography. There are a number of key points made by the author.

The first is the folly of the polarization of views in any discussion on food. Thus if you think supermarkets are a good idea, then you are seen to be opposed to local, slow food. If you are not convinced by the environmental or economic arguments for local farmers markets, then you are a supporter of global food trade. And if you eat food out of season, you are betraying the natural order of things. Rayner makes the point that you can see the great value of supermarkets while at the same time seeing the shortcomings of this sector. You can support local food suppliers but not accept the case of “food miles”. Thus food warriors who can only see slow, natural and local food are slated in his book and in my view, rightly so. In describing the case for only eating what is in season, he writes thus: ”Arguing for a food policy based on the kind of principles that would make the Amish look like a bunch of happy-go-lucky, profligate Sybarites may make a certain type of gimlet-eyed, self-regarding food warrior feel smug and self- righteous. It may make them glow with an inner purity. ‘Feel my deep well of virtue. Stroke my inner goodness”. And so on. But it will not provide a solution.”

Rayner, rightly, does not believe that the business-as-usual model will work and he recognises the need for reform of the present structure of the food chain. The UK’s capacity to feed itself, for example, fell from 70% efficiency in the mid-1990s to just 58% in 2011. In 2001, there were 2.25 million cows in Britain. By 2012, the dairy herd population had fallen to 1.85 million, all of 400,000 cows less. And the reason? Supermarket power was driving down prices paid to its suppliers such that farmers were being paid 25p per liter while the cost of production was 27p per liter. As a colleague of mine quips: “What is the difference between a supermarket buyer and a terrorist? Well, you can negotiate with a terrorist”!

Economics lies at the heart of many of the points made by the author and he has called for the establishment of a new branch of study, “gastronomics” combining gastronomy and economics. Take two examples.  In 1962 the average salary in the UK was £799 per annum. That increased 30 fold by 2012 to £26,000. In contrast, house prices in that period rose from an average of £2,670 to £245,000, an increase of 90 fold. Two incomes now became a necessity and the tedium of high street shopping in the green grocers, the grocers, the butchers, the egg man, the cheese man and so on became impossible. Welcome to the one stop shop the supermarket where you could buy everything at one visit at any time of the day. Supermarkets and women’s liberation are linked. On the other side of the coin, the global food chain has shown great vulnerability to natural and man-made events – a bad harvest in Australia, a cyclone in the Bay of Biscay, the US drive to supply the bio-ethanol industry with corn, a rise in the cost of oil which inflated farming input prices and the ever growing demand for meat and dairy products in China. In the space of 2 years between 2006 and 2008, the price of rice rose 217%, wheat by 136%, corn by 125% and soya by 107%. These massive fluctuations in food commodity prices will continue unless there is a move to ensure a stable and sustainable food chain. For supermarkets, the real problem will be supply. Local food production has fallen because supermarkets can buy the same products cheaper from elsewhere in the world where the natural advantage favours that particular food. Thus in New Zealand, the yield of apples is 50 tonnes per hectare while in the UK it is 14. However, the present monopoly of Western supermarkets might be challenged by the growing demand in economics such as China. The New Zealanders will sell apples to the buyer with the biggest purchase price, who are likely to be residents of the great Asian cities. Looking into the future, we can expect food prices to rise and we can expect some return to self-sustainability in food in individual EU states.

Prices are also a feature of his criticism of farmers’ markets: “Farmers’ markets are brilliant places. As are Ferrari showrooms, and glossy shops selling Chanel handbags. If you’ve got the cash, go right ahead. Knock yourself out”. Organic food is also slated for its feeble arguments and Rayner welcomes GM food but he states that “Biofuels are total bollocks”.

In addition to an excellent and amusing narrative about the food chain covering hunger, big agriculture and sustainable agriculture, Rayner also writes about his childhood growing up in London in a “culturally” Jewish family, his children and the hospitalization of his son with complicated appendicitis and of course his Mum, Clare Rayner the author and famous agony aunt, her life and death. This is a lovely book. Enjoy its facts, its humour and its pathos.


Monday, July 15, 2013

Vitamin D and breast fed infants

The diet of choice for infants during their first 6 months of life is exclusive breast milk. Not only is breast milk sterile and loaded with the exact nutrients an infant needs, but it also has an array of immune strengthening factors from maternal antibodies to complex carbohydrates, which promote a very health colonic microflora. Of late, however, breast milk has come under the spotlight of paediatric nutritionists because of concerns about vitamin D status in breast-fed infants. The level of exposure to sunlight largely determines vitamin D levels in blood. Thus vitamin D levels are highest as we enter winter following summer and autumn and are lowest as we enter summer following the darkness of winter and the emerging sunshine of spring. Given the high level of worry that people have about skin cancer, the use of sun blocks and possibly combined with poor dietary choices has led to quite a high frequency of low blood levels of vitamin D among adults. This has been linked to several metabolic disorders such as obesity and diabetes and these are topics, which have been extensively covered in previous blogs.

Whilst it may or may not be a problem for adults to have low levels of vitamin D in blood, it becomes an issue for mothers who are exclusively breast feeding their babies, particularly where infants are protected from UV sunlight with very high UV protection factors in sun blocks. In such cases, the infant may have insufficient dietary vitamin D and the American Academy of Pediatrics[1] have issued guidelines on the use of vitamin D supplements for exclusively breast fed infants recommending that they receive 400 International Units of oral vitamin D per day until they are weaned at 6 months.  This recommendation, issued in 2008, effectively doubled the previous recommendation and sought to ensure that the level of vitamin D in the blood of breast fed infants is at a level considered at the present time to be optimal to prevent rickets.

A recent paper published in the Journal of the American Medical Association[2] set out to directly explore the impact of varying oral doses of vitamin D on infant blood vitamin D levels. The infants were all breast fed and the study used four doses of oral vitamin D supplements (400, 800, 1200 and 1600 International Units) The study was a randomized double blind study in that infants were randomly assigned to one of the four treatments and neither the pediatric team nor the parents knew what actual dose was being given to each child. However, an independent safety monitoring officer was charged with inspecting all data as it emerged and on the instruction of this independent monitor, the dose of 1,600 IU per day was abandoned because this dose led to very high levels of blood vitamin D. Such high levels can cause calcification of soft tissue where calcium is inappropriately sequestered into non-bone or soft tissues such as the arteries and heart. All infants in this group were then re-assigned to the lowest group (400 IU/day).

The primary outcome expected by the researchers was to identify the level of vitamin D supplementation, which would lead to a blood level of vitamin D of 75 nano moles per liter in 97.5 % of infants. The results showed that this target was achieved by only 55% in those on the standard dose (400 IU/day). This % increased to 81% of infants on the 800 IU/d dose and 92% on those given 1,200 IU/d. The abandoned dose of 1,600 did achieve the target but of course was also found to increase the risk of soft tissue calculation. In effect, the study doses failed to deliver the expected outcome.

What does all this mean? To this blogger, sitting as I am now in a rare Irish heat wave, the sun is not evil. It should be respected but not feared. Obsessive use of sun protection by adults and by parents on their children and infants lies at the heart of this problem. Titrating the complex links between the levels of vitamin D in parental blood, in breast milk and in infant blood is just too complex even for clever pediatricians.  Mothers who use the sun sensibly and who allow some sun exposure to their infants, should have no problem with vitamin D deficiency in their exclusively breast fed babies. If they have any concerns, it is they who should take vitamin D supplements or enjoy butter, oily fish and liver. The level of vitamin D in plasma, which is the target of the American Academy of Pediatrics, is achieved by only 55% of infants. We urgently need studies to understand why this is so. How much is due to sun fear and how much is due to maternal nutrition? What do we know about formula fed infants? Why was such a group not included in this study? This is all a work in progress.



[1] Wagner CL (2008), Pediatrics, 122, 1142-1152
[2] Gallo S et al (2013) JAMA, 309, 1785-1792

Monday, July 8, 2013

Nutrition's blind spot: Macular degeneration

The retina is the site for the capturing of visual images in the eye and it is often likened to the camera film of the eye. The central part of the retina is called the macula. It is a tiny spot of about 1.4 millimeters and is yellow in colour due to the high concentration of the pigment, lutein. Although it is tiny, the macula contains the largest concentration of cone cells, which are responsible for central high-resolution vision. With aging, the macula becomes prone to damage and this age-related macular degeneration (ARMD) is the major cause of loss of central vision in older persons. Effectively, the central field of vision becomes dysfunctional while the peripheral vision remains unaffected. Reading or using a computer, becomes impossible while other activities of daily life remain unaffected. Some types of ARMD are amenable to treatment with drugs while for others there is no treatment and thus there has been a drive to seek out preventative measures.

In 2001, researchers from the US National Eye Institute were the lead authors on a paper which reported that a daily oral supplement with certain minerals and vitamins, reduced the risk of developing advanced ARMD by 25% over a 5 year period[1]. The research was prompted by several small studies, which suggested a role for certain antioxidant micronutrients in preventing ARMD. However whereas these small studies were insufficient to build up a solid base of evidence, they spurned a phenomenal growth in the sales of food supplements with very questionable claims. Thus the study, known as The Age Related Eye Disease Study (AREDS), enrolled 3,640 subjects with ARMD to test the hypothesis that certain micronutrients might reduce the progressions of the disease. The results showed a reduction in ARMD progression with daily supplements of vitamin C, vitamin E, beta-carotene, zinc and copper.

In May of this year, a second AREDS paper was reported in the Journal of the American Medical Association[2]. This study sought to further explore whether additional micronutrients might enhance the effects of the first AREDS micronutrient cocktail. The first of the micronutrients was lutein, which is found in high concentration in the macula. It is synthesised only by plants, particularly green leafy plants and in the eye, serves to protect the retina from damage arising through the high-energy photons of blue light.  Zeaxanthin, the second micronutrient is also involved in photo quenching in the macula and, again, it is a plant derived compound. The final two additional compounds examined were the very long chain polyunsaturated fatty acids found in high concentration in oily fish and which also form a main element of the surrounding of nerve calls (the myelin sheath). The eye is a very heavily innervated organ. The outcome of this second AREDS study was that there was no additional benefit to be had over and above what had been achieved with the original AREDS cocktail (vitamin C, vitamin E, beta-carotene, zinc and copper).

Yet another paper[3] recently focused on other micronutrients and their role in ARMD, specifically two B vitamins, folic acid and vitamin B12. Volunteers had retinal photographs taken 5 to 10 years apart and the incidence of ARMD was ascertained using these retinal photographs. At entry into the study, subjects complete a food frequency questionnaire, which was used to ascertain habitual folic acid and B12 intakes. Blood samples were taken to ascertain the biochemical status of the vitamins. The use of nutritional supplements was also recorded. After statistical adjustment for such confounding factors as age, smoking, gender, and so on, those deemed to be deficient in folic acid status using blood measures, had an 89% increased risk of ARMD. B12 deficiency increased the 10-year risk of ARMD by about 60%. Those subjects who were regular users of food supplements had a 47% lower risk of macular degeneration. This study was observational and cannot prove cause and effect for which a long-term intervention study (such as AREDS 1 and 2) is needed.

 ARMD accounts for more than 50% of all blindness in the US and the numbers affected will grow from about 2 to 4 million by 2025. Clearly, ARMD will continue to be a major area of public health nutrition. And once again, all this research shows that the old adage that all your nutrients can be had derived entirely from a health diet isn’t true. No doubt it is true for some but not all and nutrigenetics will soon reveal who is most sensitive to low micronutrient intakes in relation to ARMD.




[1] Age Related Eye Disease Study (AREDS 1) Group (2001) Arch Opthalmol, 119, 1417-1436
[2] Age Related Eye Disease Study (AREDS 2) Group (2013) JAMA, 309, 2005-2015
[3] Gopinath B et al (2013) AJCN, 98, 129-135

Monday, July 1, 2013

Hunger

A TEDx talk I gave entitled Hunger.


https://www.youtube.com/watch?v=n2wrP4FS1Bs

Sunday, June 30, 2013

Fat spat: Scientists argue over obesity risks


I have long argued that dissent is the oxygen of science and that whereas unanimity of opinion is fine for political parties and religious organisations, it has no place in science. Indeed, I have always held the view that the unexpected finding in science is its jewel. It is not a view that is widely held since science tends to be protective of its theories and dislikes having its conventional wisdom challenged. Right now, a major row has broken out over the true health risks of being moderately overweight. There are two dimensions to this squabble, the scientific dimension and the policy dimension. Let’s start with the science.

Katherine Flegal is a scientist at the US National Center for Health Statistics and she specialises in the study of the obesity epidemic in the US. In January of this year, Flegal and her colleagues published a paper in the Journal of The American Medical Association[1] in which she showed that persons who were overweight but not obese, had a statistically lower chance of dying than persons with a bodyweight deemed to be within the normal range. Her paper was based on a systematic review of the scientific literature on obesity in which she searched the literature for any study that involved the use of standardised classes of body weight (body mass index: BMI) and which involved a follow up period from baseline measures that allowed for an estimate of the relative risk of mortality across different standardised classes of BMI. She included all languages in her search and also excluded studies that failed to use the standard BMI classes, involved adolescents or which involved subjects with specific medical conditions. In all, she included 97 studies, which involved 2.88 million people with a total number of deaths in follow-up of 270,000. The papers were selected initially by Flegal but were included in the analysis only with the unanimous agreement of three independent reviewers. Top science here!

Her findings that overweight people had a 6% lower risk of mortality than normal weight individuals wasn’t new but it was a massively comprehensive study compared to all previous studies, which had shown this effect. The Journal commissioned a guest editorial on the paper from Dr Steven Heymsfield, Director of the Pennington Institute in Baton Rouge, a center of excellence in obesity research[2].  This editorial notes that: “Body Mass Index is an imperfect predictor of metabolic risk” and concludes by stating that: “Establishing BMI is only the first step toward a more comprehensive risk evaluation”. So, let’s pause here. We have one of America’s leading statisticians on the obesity epidemic publishing the most comprehensive paper of its kind in this field in a top academic journal following the normal rigors of peer review and we have a very supportive guest editorial by the director of the leading obesity research centre in the US.

However, the dons at the Harvard School of Public Health were not happy. Led by Professor Walter Willett, they held a special meeting to line up critics of the Flegal paper. In a radio interview[3], Willet stated: “This study is really a pile of rubbish and no one should waste their time reading it”. This in turn led to an editorial in Nature[4] and an overview article entitled “The big fat truth” by science journalist Virginia Hughes.[5]  She reviews some literature and draws on data, which shows that the relationship between BMI and mortality varies greatly with age. In older people, at the lower and at the upper spectrum of BMI, the risk of mortality is higher than it is for the majority of the population who are neither too skinny nor too fat. In younger people, the lower low BMI values are not associated with elevated risk.

Leaving the science aside, there is a critically important aspect to this row that needs highlighting. Think back to the BSE crisis. At that point, within the EU we had the risk assessment process and the risk management process both operated by the European Commission. That was then amended to take the risk assessment process away from the Commission and to create a totally science- based independent body, The European Food Safety Authority, to conduct risk assessment. The Harvard group is effectively seeking to be both risk assessors and risk managers. The former is science based and the latter is politically or policy based. If the two are attended to within the same institute, as the Harvard group seem to want, then the risk management process will filter the risk assessment process. Why support a scientific paper, which conflicts with your risk management goals? Indeed, in this week’s Harvard Gazette which covered this controversy, Professor Willett is quoted thus: “If you don’t have the right goal you are very unlikely to end up in the right place”[6]. Clearly, Professor Willett knows what is “right” and those who differ are “wrong”. This is simply bad for science. As I said, dissent is the oxygen of science.






[1] Flegal KM et al (2013) JAMA, 309 (1) 71-82
[2] Hyemsfield SB (2013) JAMA, 309, 87-88
[4] “Shades of grey” Nature (2013), 497, 410
[5] “The big fat truth” Hughes V (2013) Nature 497, 428-430